These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8164225)

  • 1. Exaggerated fibrosis in patients with systemic sclerosis (scleroderma) following radiation therapy.
    Abu-Shakra M; Lee P
    J Rheumatol; 1993 Sep; 20(9):1601-3. PubMed ID: 8164225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and localized scleroderma.
    Chung L; Lin J; Furst DE; Fiorentino D
    Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exaggerated radiation-induced fibrosis in patients with systemic sclerosis.
    Varga J; Haustein UF; Creech RH; Dwyer JP; Jimenez SA
    JAMA; 1991 Jun; 265(24):3292-5. PubMed ID: 2046111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: severe fibrosis in a patient with scleroderma and previous radiotherapy--a case report and literature review.
    Aref I; Cross P; Nair B
    Br J Radiol; 1996 Nov; 69(827):1055-6. PubMed ID: 8958027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
    Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
    J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy.
    Riekki R; Harvima IT; Jukkola A; Risteli J; Oikarinen A
    Exp Dermatol; 2004 Jun; 13(6):364-71. PubMed ID: 15186323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic systemic fibrosis: a histopathological study of eight cases of a recently described entity.
    Digby S; Macduff E; Blessing K; Holmes S
    Histopathology; 2008 Mar; 52(4):531-4. PubMed ID: 18315613
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis.
    Salmon-Ehr V; Serpier H; Nawrocki B; Gillery P; Clavel C; Kalis B; Birembaut P; Maquart FX
    Arch Dermatol; 1996 Jul; 132(7):802-6. PubMed ID: 8678573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma.
    Higashi-Kuwata N; Makino T; Inoue Y; Takeya M; Ihn H
    Exp Dermatol; 2009 Aug; 18(8):727-9. PubMed ID: 19320738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased pigmentation in scleroderma.
    Pope JE; Shum DT; Gottschalk R; Stevens A; McManus R
    J Rheumatol; 1996 Nov; 23(11):1912-6. PubMed ID: 8923365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary localized cutaneous amyloidosis in patients with scleroderma.
    Kikuchi N; Sakai E; Nishibu A; Ohtsuka M; Yamamoto T
    Acta Derm Venereol; 2010 May; 90(3):326-7. PubMed ID: 20526567
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scleroderma-like disorders.
    Foti R; Leonardi R; Rondinone R; Di Gangi M; Leonetti C; Canova M; Doria A
    Autoimmun Rev; 2008 Feb; 7(4):331-9. PubMed ID: 18295739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies on the reaction of acid mucopolysaccharide in sclerosis of the skin after betatron radiation, in scleroderma and some sclerosing dermatoses].
    Ishikawa H; Thies W; Schumacher W; Klaschka F
    Hautarzt; 1967 Apr; 18(4):174-80. PubMed ID: 4171962
    [No Abstract]   [Full Text] [Related]  

  • 17. Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
    Sunderkötter C; Kuhn A; Hunzelmann N; Beissert S
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii52-iii54. PubMed ID: 16987838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
    Khurram M; Skov L; Rossen K; Thomsen HS; Marckmann P
    Scand J Urol Nephrol; 2007; 41(6):565-6. PubMed ID: 17934986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleromyxedema: a scleroderma-like disorder with systemic manifestations.
    Gabriel SE; Perry HO; Oleson GB; Bowles CA
    Medicine (Baltimore); 1988 Jan; 67(1):58-65. PubMed ID: 3336281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital thermal hyperaemia impairment does not relate to skin fibrosis or macrovascular disease in systemic sclerosis.
    Salvat-Melis M; Carpentier PH; Minson CT; Boignard A; McCord GR; Paris A; Moreau-Gaudry A; Cracowski JL
    Rheumatology (Oxford); 2006 Dec; 45(12):1490-6. PubMed ID: 16705051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.